Answer
Signifor (pasireotide diaspartate) is self-injected subcutaneously after instruction from a physician or healthcare professional, preferably into the upper thighs or abdomen excluding the navel and waistline, avoiding inflamed or irritated areas and not using the same site for consecutive injections.
Sources for this answer
- Signifor 0.3 mg solution for injectionRecordati Rare Diseases UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 18Document updated
Sources checked